AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 247: G261-G264, 1984;
0193-1857/84 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howard, J. M.
Right arrow Articles by Gardner, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Howard, J. M.
Right arrow Articles by Gardner, J. D.

AJP - Gastrointestinal and Liver Physiology, Vol 247, Issue 3 261-G264, Copyright © 1984 by American Physiological Society

ARTICLES

Discovery of a cholecystokinin analogue with partial agonist activity

J. M. Howard, M. Knight, R. T. Jensen and J. D. Gardner

In dispersed acini from guinea pig pancreas, cholecystokinin-(27-32)-amide [CCK-(27-32)-NH2] did not stimulate amylase secretion and inhibited the stimulation caused by CCK-(26-33). In dispersed acini from mouse or rat pancreas, CCK-(27-32)-NH2 stimulated amylase secretion. The stimulation of amylase secretion caused by a maximally effective concentration of CCK-(27-32)-NH2 was less than that caused by a maximally effective concentration of cholecystokinin-(26-33), and in contrast to the action of cholecystokinin-(26-33) supramaximal concentrations of CCK-(27-32)-NH2 did not cause submaximal stimulation of amylase secretion. Dibutyryl cGMP and proglumide each inhibited the stimulation of amylase secretion caused by CCK-(27-32)-NH2. CCK-(27-32)-NH2 inhibited binding of 125I-labeled CCK to mouse and rat pancreatic acini. These results indicate that, in mouse and rat pancreatic acini, CCK-(27-32)-NH2 is a partial agonist and that this partial agonist activity is produced by occupation of the CCK receptor by CCK-(27-32)-NH2.


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
R. R. Ryan, T. Katsuno, S. A. Mantey, T. K. Pradhan, H. C. Weber, D. H. Coy, J. F. Battey, and R. T. Jensen
Comparative Pharmacology of the Nonpeptide Neuromedin B Receptor Antagonist PD 168368
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1202 - 1211.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
V. Gigoux, C. Escrieut, J.-A. Fehrentz, S. Poirot, B. Maigret, L. Moroder, D. Gully, J. Martinez, N. Vaysse, and D. Fourmy
Arginine 336 and Asparagine 333 of the Human Cholecystokinin-A Receptor Binding Site Interact with the Penultimate Aspartic Acid and the C-terminal Amide of Cholecystokinin
J. Biol. Chem., July 16, 1999; 274(29): 20457 - 20464.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online